- Home
- NVA vs RPID Comparison
NVA vs RPID Comparison
Compare NVA & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVA
- RPID
- Stock Information
- Founded
- NVA 1987
- RPID 2006
- Country
- NVA Australia
- RPID United States
- Employees
- NVA N/A
- RPID N/A
- Industry
- NVA
- RPID Medical Specialities
- Sector
- NVA
- RPID Health Care
- Exchange
- NVA NYSE
- RPID Nasdaq
- Market Cap
- NVA 33.3M
- RPID 37.3M
- IPO Year
- NVA N/A
- RPID 2021
- Fundamental
- Price
- NVA $7.90
- RPID $1.04
- Analyst Decision
- NVA
- RPID
- Analyst Count
- NVA 0
- RPID 0
- Target Price
- NVA N/A
- RPID N/A
- AVG Volume (30 Days)
- NVA 85.5K
- RPID 128.8K
- Earning Date
- NVA 01-01-0001
- RPID 11-01-2024
- Dividend Yield
- NVA N/A
- RPID N/A
- EPS Growth
- NVA N/A
- RPID N/A
- EPS
- NVA N/A
- RPID N/A
- Revenue
- NVA N/A
- RPID $26,170,000.00
- Revenue This Year
- NVA N/A
- RPID $24.34
- Revenue Next Year
- NVA N/A
- RPID $19.49
- P/E Ratio
- NVA N/A
- RPID N/A
- Revenue Growth
- NVA N/A
- RPID 27.31
- 52 Week Low
- NVA $4.35
- RPID $0.58
- 52 Week High
- NVA $12.65
- RPID $1.34
- Technical
- Relative Strength Index (RSI)
- NVA N/A
- RPID 48.03
- Support Level
- NVA N/A
- RPID $1.16
- Resistance Level
- NVA N/A
- RPID $1.30
- Average True Range (ATR)
- NVA 0.00
- RPID 0.11
- MACD
- NVA 0.00
- RPID -0.01
- Stochastic Oscillator
- NVA 0.00
- RPID 3.23
About NVA NOVA MINERALS LTD SPON ADS EACH REP 60 ORD
Nova Minerals Ltd is a minerals explorer and developer focused on gold and lithium projects in North America a Gold, Antimony, focused on advancing the Estelle Project. It also includes other projects such as , Barrick's Donlin Creek Gold Project and Kinross Gold Corporation's Fort Knox Gold Mine.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.